Artennua

Artennua is a Spanish biotechnology company focused on the optimized cultivation of Artemisia annua to produce high concentrations of artemisinin and other beneficial secondary metabolites. Utilizing a proprietary biostimulation technology and controlled environmental conditions, the company produces pharmaceutical-grade plant material with significantly higher active ingredient content than wild or standard cultivated varieties. Their primary focus is on the development of natural solutions for animal and human health, particularly targeting leishmaniasis in the veterinary market and immune system modulation. The company operates a specialized production facility in the Canary Islands, leveraging the unique climate to enhance plant growth and chemical profile.